证券代码：301092 证券简称：争光股份 公告编号：2025-028 浙江争光实业股份有限公司 关于注销部分募集资金专户的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完 整，没有虚假记载、误导性陈述或重大遗漏。 一、募集资金的情况概述 （二）募集资金投资项目情况 （一）募集资金的基本情况 根据中国证券监督管理委员会于 2021 年 8 月 27 日出具的《关于 同意浙江争光实业股份有限公司首次公开发行股票注册的批复》（证 监许可〔2021〕2803 号），浙江争光实业股份有限公司（以下简称 "公司"）首次公开发行人民币普通股（A）股 3,333.3334 万股，每 股发行价格为 36.31 元，募集资金总额为人民币 121,033.34 万元； 扣除发行费用后实际募集资金净额为人民币 109,997.56 万元。上述 募集资金已于 2021 年 10 月 25 日全部到账，并经天健会计师事务所 （特殊普通合伙）对公司首次公开发行股票的资金到位情况进行了审 验，并于 2021 年 10 月 25 日出具了《验资报告》（天健验〔2021〕 580 号）。公司及子公司已对募集资金进行专户管理，并与开 ...

Fundraising Overview - Zhejiang Zhangguang Industrial Co., Ltd. successfully raised a total of RMB 121,033.34 million through its initial public offering, with a net amount of RMB 109,997.56 million after deducting issuance costs [1][3] - The company issued 33,333,334 shares at a price of RMB 36.31 per share, and the funds were fully received by October 25, 2021 [1][3] Investment Projects - The raised funds are allocated to two main projects: 1. A production line for 15,000 tons of food-grade resin and intelligent warehouse technology renovation, with a total investment of RMB 37,692 million [2][3] 2. The establishment of an ion exchange resin technology research and development center at Ningbo Zhangguang Resin Co., Ltd. [3] Management of Raised Funds - The company has established special accounts in various banks to manage the raised funds, ensuring compliance with regulatory requirements and protecting investor interests [4][5] - The funds are stored in dedicated accounts for specific projects, including the food-grade resin production line and the ion exchange resin R&D center [4][5] Use of Excess Funds - The company has excess raised funds amounting to RMB 72,305.56 million, which will be used to permanently supplement working capital and invest in functional high polymer new materials projects [3][4] Account Closure - The company has completed the closure of certain fundraising special accounts related to the factory automation upgrade project, as the funds have been fully utilized [5]

证券代码：301092 证券简称：争光股份 公告编号：2025-027 浙江争光实业股份有限公司 关于注销部分募集资金专户的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完 整，没有虚假记载、误导性陈述或重大遗漏。 一、募集资金的情况概述 （一）募集资金的基本情况 根据中国证券监督管理委员会于 2021 年 8 月 27 日出具的《关于 同意浙江争光实业股份有限公司首次公开发行股票注册的批复》（证 监许可〔2021〕2803 号），浙江争光实业股份有限公司（以下简称 "公司"）首次公开发行人民币普通股（A）股 3,333.3334 万股，每 股发行价格为 36.31 元，募集资金总额为人民币 121,033.34 万元； 扣除发行费用后实际募集资金净额为人民币 109,997.56 万元。上述 募集资金已于 2021 年 10 月 25 日全部到账，并经天健会计师事务所 （特殊普通合伙）对公司首次公开发行股票的资金到位情况进行了审 验，并于 2021 年 10 月 25 日出具了《验资报告》（天健验〔2021〕 580 号）。公司及子公司已对募集资金进行专户管理，并与开户银行、 保荐人签署了募集资 ...

证券代码：301092 证券简称：争光股份 公告编号：2025-026 1、浙江争光实业股份有限公司（以下简称"公司"）回购专用证 券账户中的股份 428,000.00 股不参与本次权益分派。公司 2024 年年 度权益分派方案为：以总股本扣除已回购股份 428,000.00 股后的 133,625,484.00 股为基数，向全体股东每 10 股派发现金红利 2.6 元 人民币，实际派发现金分红总额=133,625,484 股×2.6 元/10 股= 34,742,625.84 元（含税）。 2、本次权益分派实施后计算除权除息价格时，按总股本（含回 购股份）折算的每 10 股现金红利（含税）=现金分红总额/总股本 *10=34,742,625.84 元/134,053,484 股*10 股=2.591698 元（保留六 位小数，最后一位直接截取，不四舍五入）。 3、本次权益分派实施后除权除息参考价=除权除息日前一交易 日收盘价-按总股本（含回购股份）折算每股现金红利=除权除息日前 一交易日收盘价-0.2591698 元/股（按公司总股本折算每股现金分红 金额，不四舍五入）。 公司2024年年度权益分派方案已获 ...

编号：2025-003 | | 特定对象调研 分析师会议 | | --- | --- | | 投资者关系活动 | 媒体采访 业绩说明会 | | 类别 | 新闻发布会 路演活动 | | | 现场参观 | | | 其他（请文字说明其他活动内容） | | 参与单位名称及 | 通过全景网"投资者关系互动平台"（https://ir.p5w.net）参 | | 人员姓名 | 与公司 2024 年度网上业绩说明会的投资者 | | 时间 | 2025 年 5 月 22 日(周四)下午 15:00～17:00 | | 地点 | 全景网"投资者关系互动平台"（https://ir.p5w.net） | | 上市公司接待人 | 1、董事长、总经理：沈建华 | | | 2、副总经理、董事会秘书、财务负责人：吴雅飞 | | 员姓名 | 3、独立董事：金浪 | | | 4、保荐代表人：陶祖海 投资者提出的问题及公司回复情况 | | | 公司就投资者在本次说明会中提出的问题进行了回复： | | | 1、请问荆门项目什么时候投产，有具体的客户吗 | | | 您好，目前该项目正在抓紧建设当中，预计 2025 年年底开 | | ...

本公司及董事会全体成员保证信息披露内容的真实、准确和完 整，没有虚假记载、误导性陈述或重大遗漏。 浙江争光实业股份有限公司(以下简称"公司")董事会近日收到 公司非独立董事王焕军先生的辞职报告，其因个人原因，申请辞去公 司第六届董事会非独立董事及审计委员会委员职务，其辞职后将不再 担任公司的其他职务。 证券代码：301092 证券简称：争光股份 公告编号：2025-025 浙江争光实业股份有限公司 关于公司非独立董事辞职的公告 特此公告。 浙江争光实业股份有限公司董事会 2025 年 5 月 20 日 指引第 18 号——股东及董事、高级管理人员减持股份》等相关法律、 法规和规范性文件关于股份变动的相关规定及其本人已作出的相关 承诺。 公司及公司董事会对王焕军先生在任职期间为公司做出的贡献 表示衷心的感谢！ 根据《深圳证券交易所上市公司自律监管指引第 2 号——创业板 上市公司规范运作》等法律法规、规范性文件和《公司章程》的有关 规定，王焕军先生的辞职不会导致公司董事会成员人数低于法定人数， 不会影响董事会的正常运行，其辞职报告自送达公司董事会之日起生 效。公司将按照法定程序尽快完成相关补选工作。 王焕军先生 ...

地址：杭州市上城区老复兴路白塔公园 B 区 2 号、15 号国浩律师楼 邮编：310008 国浩律师（杭州）事务所 关于 浙江争光实业股份有限公司 2024 年年度股东大会 之 法律意见书 Grandall Building, No.2＆No.15, Block B, Baita Park, Old Fuxing Road, Hangzhou, Zhejiang 310008, China 电话/Tel: (+86)(571) 8577 5888 传真/Fax: (+86)(571) 8577 5643 电子邮箱/Mail：grandallhz@grandall.com.cn 网址/Website：http://www.grandall.com.cn 二〇二五年五月 国浩律师（杭州）事务所 法律意见书 国浩律师（杭州）事务所 关于浙江争光实业股份有限公司 2024 年年度股东大会之 法律意见书 致：浙江争光实业股份有限公司 国浩律师（杭州）事务所（以下简称"本所"）接受浙江争光实业股份有限 公司（以下简称"公司"）委托，指派律师出席公司 2024 年年度股东大会（以下 简称"本次股东大会"），并依据《中华人民 ...

证券代码：301092 证券简称：争光股份 公告编号：2025-024 浙江争光实业股份有限公司 2024年年度股东大会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 1、本次股东大会没有出现否决议案的情况； 2、本次股东大会不涉及变更以往股东大会已通过决议的情况； 3、本次股东大会以现场与网络投票相结合的方式召开。 一、会议召开和出席的情况 （2）网络投票时间： 通过深圳证券交易所交易系统进行网络投票的具体时间为：2025年5月19日 上午9:15-9:25，9:30-11:30，下午13:00-15:00；通过深圳证券交易所互联网投 票系统投票的具体时间为：2025年5月19日9:15—15:00期间的任意时间。 2、会议召开方式：本次股东大会采取现场投票与网络投票相结合的方式。 3、会议召开地点：杭州市临平区南苑街道世纪大道1号美亚大厦16楼公司会 议室。 4、会议召集人：公司第六届董事会。 5、会议主持人：公司董事长沈建华。 6、会议召开的合法、合规性：本次股东大会的召集、召开符合有关法律、 行政法规、部门规章、规范性文件和《公司 ...

Summary of the Conference Call for Zhangguang Co., Ltd. Company Overview - Zhangguang Co., Ltd. is a leading enterprise in the domestic ion exchange resin sector, particularly strong in nuclear industry applications, and is actively expanding into high-end niche markets such as electronic-grade and biopharmaceuticals, benefiting from accelerated domestic substitution [2][4][5] Industry Position and Market Dynamics - The company has a significant market position in the ion exchange resin industry, being a standard setter and holding a market share of approximately 70% in domestic sales, with 20%-30% in overseas sales [2][10] - The impact of the US-China trade war on the company is limited, with sales to the US accounting for only about 20 to 30 million yuan, presenting new opportunities through domestic substitution, especially in thermal power, nuclear power, and supercritical fluid sectors [7][8] Capacity Expansion and Production - The company has been continuously expanding its production capacity, with new products launched in 2024 including 2,300 tons of macroporous adsorption resin and 15,000 tons of food-grade refined treatment resin. In Q4 2025, the Jinmen project will add 55,000 tons of capacity, with gradual ramp-up expected in 2026 [2][6] - The Ningbo base has maintained full production and sales status, with new capacity expected to optimize product structure and enhance the proportion of mid-to-high-end products, leading to potential improvements in gross margin and pricing [11][12] Product Portfolio and Applications - The main products include acrylic resins and styrene-based resins, widely used in semiconductor manufacturing and biopharmaceuticals [10][20] - The company is focusing on electronic-grade polishing resins, having achieved stable supply for panels and testing samples for downstream suppliers like Yangtze Memory Technologies [3][23] Financial Performance and Future Outlook - The company has shown steady growth since 2011, with current annual revenue from the Ningbo base around 500 to 600 million yuan and profits between 110 to 130 million yuan, primarily from industrial water treatment and food-grade applications [16] - The company anticipates a significant performance increase with the full production of the Jinmen project, potentially doubling or tripling its earnings in the medium to long term [26] Shareholding Structure and Management - The shareholding structure is concentrated, with the major shareholder holding approximately 52% and the core management team holding about 60% to 70%. There are no short-term plans for share reduction, but future capital market operations may support new projects [9] Competitive Landscape - The ion exchange resin industry is characterized by a three-tier competitive structure, with top-tier companies being established overseas brands, followed by domestic firms like Zhangguang and Blue Sky Technology, and a third tier of numerous small enterprises [18] Strategic Initiatives and Collaborations - The company is making strides in domestic substitution across various sectors, including food-grade and electronic semiconductors, with significant progress in nuclear industry applications [15][24] - Collaborations in the biopharmaceutical sector are ongoing, with laboratory product samples already sent to downstream customers, indicating positive feedback [25] Valuation and Profitability Forecast - The company is projected to have a PE ratio of 34 times in 2025, above the industry average of 23 times, but with a PEG ratio of 0.3 times in 2026, indicating better value compared to the industry average of 0.8 times. Earnings are expected to reach around 200 million yuan in 2026 and 260 million yuan in 2027, suggesting significant growth potential [27]

Report Summary 1. Report Industry Investment Rating There is no information about the industry investment rating in the provided content. 2. Core Viewpoints of the Report - The company has traditional advantages in the nuclear power field and has launched import - substitution products in cooperation with relevant national nuclear technology authorities, which have entered into practical application. It is also carrying out R & D and promotion in the battery recycling and solar polysilicon fields [21]. - The company aims to gain more market share in the mid - high - end water treatment market, as there is a large space for import substitution in high - value - added products for condensate water treatment [21]. - The completion of the company's fundraising projects will enhance its core competitiveness, reduce labor costs, increase production efficiency, and meet market demand [22]. - The company's Jingmen production base focuses on new energy, environmental protection, and biomedicine fields, and is expected to start trial production by the end of 2025 and reach the intended use state by the end of April 2026 [22]. - According to the 2024 annual profit distribution plan, the company plans to distribute a cash dividend of 2.60 yuan per 10 shares (tax - included) to all shareholders, and future dividend plans will be determined based on specific circumstances [22][23]. 3. Summary by Relevant Catalogs 3.1. Research Basic Situation - The research object is Zhengguang Co., Ltd., belonging to the chemical products industry. The reception time was May 15, 2025. The listed company's reception personnel included the deputy general manager, board secretary, financial director Wu Yafei, and the securities affairs representative Che Cheng [16]. 3.2. Detailed Research Institutions - The research institutions include Huian Fund (represented by Wang Minglu), Huihong Asset (represented by Zhang Li), Nuoyan Fund (represented by Zhou Xiaoqi), CITIC Securities (represented by Sun Chenxing), PICC Asset (represented by Tian Lei), Guotai Haitong (represented by Wang Ruijian), and CICC (represented by Ye Endong) [17]. 3.3. Research Institutions Proportion There is no information about the research institutions proportion in the provided content. 3.4. Main Content Data - **Company Introduction**: The board secretary introduced the company's basic and operating conditions, as well as industry and product information [21]. - **New Energy Progress**: The company has advantages in the nuclear power field, and is also involved in battery recycling and solar polysilicon R & D [21]. - **Mid - High - End Water Treatment Market Goals**: The company aims to gain more share in this market, with large import substitution space for condensate water treatment resin [21]. - **Fundraising Project Completion**: As of the end of 2024, some projects have been completed, which will enhance the company's competitiveness [22]. - **Jingmen Production Base**: Focuses on new energy, environmental protection, and biomedicine, expected to start trial production by the end of 2025 and reach normal operation by April 2026 [22]. - **Dividend Situation**: Plans to distribute a cash dividend of 2.60 yuan per 10 shares in 2024, and future dividends will be determined according to circumstances [22][23].